Clinical Trial Update: Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hydroxychloroquine for endothelial dysfunction in antiphospholipid syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Antiphospholipid Syndrome (APS) | Phase 2 | Status: TERMINATED